Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
about
Acinetobacter baumannii Infection and IL-17 Mediated ImmunityAcinetobacter baumannii: an emerging opportunistic pathogenAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideIdentification of novel regulatory small RNAs in Acinetobacter baumanniiIdentification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formationImmunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis modelsInsect Antimicrobial Peptide Complexes Prevent Resistance Development in BacteriaEndemic Acinetobacter baumannii in a New York hospitalBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsAcinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospitalRisk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia.Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles.Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility.Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.ISAba825, a functional insertion sequence modulating genomic plasticity and bla(OXA-58) expression in Acinetobacter baumanniiSmall-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.Whole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells.Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistanceHorizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channelComparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinantsMolecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care unitsResources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumanniiIn Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic TreatmentRisk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West ChinaColistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosaTranslation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding ProteinHeteroresistance to cephalosporins and penicillins in Acinetobacter baumanniiAcinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to ResistanceHigh prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.Epidemiology and Cytokine Levels among Children with Nosocomial Multidrug-Resistant Acinetobacter baumannii Complex in a Tertiary Hospital of Eastern ChinaActivity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.Meta-analysis of colistin for the treatment of Acinetobacter baumannii infectionIn Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.Non-nucleoside inhibitors of BasE, an adenylating enzyme in the siderophore biosynthetic pathway of the opportunistic pathogen Acinetobacter baumannii.Stress responses in the opportunistic pathogen Acinetobacter baumannii.
P2860
Q26765767-C526D85A-79F0-43D7-8F8C-49A5E9FAB649Q26830893-FDDE9381-C6B9-4A1E-8CCB-08E96BC53799Q27024893-83C26F82-DEE9-458E-B0FF-E0DDF6C6E283Q28237546-0FC3B989-E6D8-4BBE-95EB-1B0168097646Q28484155-2FBC6AEE-6AAC-4BA3-8AA9-97EFEBB48530Q28539933-811FD9D6-75E3-490F-A18E-A6AB424C7AA7Q28546527-182B6A92-186C-4093-B9C6-16B92A80C2E5Q28741550-E89B3DE6-3184-4A8D-8F4D-16E364599E28Q30235064-FD71C52D-94C2-4897-B55C-69074EF48623Q31113551-6CFD6B65-654C-467D-B13D-3FC69E696158Q33610935-C3581B6D-80C6-415D-AC1F-CDC204F5652FQ33633989-2D8D9D3F-FBB3-445B-94B7-B49292B36004Q33840920-EF4EA996-5807-47C4-B3CB-92C621BB7572Q33914214-8269D01C-25A9-4101-B7EC-D461A34195FAQ34168292-B622151D-62DB-475B-A606-20B7A47B2446Q34288902-EC472AC9-D006-4A01-B63A-B7E6E692149BQ34529149-5B47576C-9BC5-41C2-A82E-0C4790653723Q34823364-D6846398-7AA2-4BE3-8E04-17EC741A4A68Q34983666-51D913F1-CD57-4C60-8759-C7D66222DA62Q35139329-A56919AE-ECF2-4E2A-9536-83A03C8FEB05Q35192521-46339192-07A6-46FC-A5FE-A977274CE582Q35201119-A78117C5-E3DC-4C51-A527-B8067B09D956Q35230346-177CBCF7-4598-4525-9483-3CCA7D447E3CQ35595613-B7A8EB70-7A6C-4D6E-AC83-1146AFB0455FQ35662086-7BAD1A9A-D723-44C7-96F2-50EF0615EC71Q35666047-14D456F2-8770-4FF0-ACE4-AE5139663678Q35666622-F133D429-EA08-488E-8358-7E655922EC81Q35731104-A01FDD50-DFF3-4572-809C-EEA245096769Q35807220-A9077C28-E379-4B1F-9678-73A9FD1B38E5Q35816112-FD4CDCFB-816D-4B4E-9FDB-839E49DFB64DQ35843094-00B66BC0-F522-4794-8407-1067F4D19A27Q36018796-14BF934E-5F49-4B36-9532-3E414D3C9D3AQ36118322-76707238-0FFD-4E90-9E6A-4793BE29E3D1Q36198451-E3647BA9-E670-4FE5-BF48-252E0D49F9ACQ36310173-33AD3C8B-B9D2-4AE9-98AD-C69D6BC498EAQ36465442-A2507CA4-1378-4F31-837E-56E0F6F7AE48Q36604103-51F3013A-7F4C-469F-8478-42182C368EB9Q36628128-A9181B9E-C840-49FD-AE89-352FE5E6C8E2Q36752164-08ABEDE5-BF22-4523-A222-2ADC32F77345Q36800492-19C3AF3C-F79C-4F7A-83BE-3B4EF42D45CF
P2860
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
@en
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
@nl
type
label
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
@en
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
@nl
prefLabel
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
@en
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
@nl
P1476
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
@en
P304
P356
10.1016/J.IJANTIMICAG.2009.10.024
P577
2010-01-04T00:00:00Z